Study identifies best imaging methods for evaluating brain tumor response in melanoma patients
Raymond Y. Huang, MD, Ph.D., of the Department of Radiology at Brigham and Women's Hospital, is the corresponding author of a ...
Tag: Melanoma
Combination therapy shows promising results in treating stage 3 melanoma
Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of ...
P-stalk ribosomes identified as key regulators of immune evasion in cancer
New study reveals that specialized ribosomes, driven by cytokine signals, help tumors evade the immune system, offering a breakthrough pathway ...
Antibody-drug conjugate shows promise in treating ovarian and endometrial cancers
Studies reported at ESMO 2024 reveal new groups of women with early-stage endometrial and cervical cancers who gain clinically meaningful benefit ...
Distinct waves of T cells generated by each dose of combination immunotherapy
A new tool for monitoring immune health patterns over time has revealed how a pair of checkpoint inhibitor therapies works ...
New insights on how melanoma cells resist cancer immunotherapy
How would you summarize your study for a lay audience? Immune checkpoint inhibitors are cancer fighting drugs that help the ...
Study reveals metabolic switch crucial for memory T cell formation and cancer immunity
A Ludwig Cancer Research study has identified a metabolic switch in the immune system's T cells that is essential to ...
EZH2's role in cancer progression and therapy explored
Enhancer of zeste homolog 2 (EZH2) is a catalytic subunit of the Polycomb-repressive complex 2 (PRC2), which plays a crucial ...
CD5 knockout using CRISPR boosts CAR T cell therapy efficacy
The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by ...
AI-based liquid biopsy technology promises early detection of cancer recurrence
An artificial intelligence-powered method for detecting tumor DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, in a ...
